Harrow Inc (HROW)
16.76
+0.60
(+3.71%)
USD |
NASDAQ |
May 17, 16:00
16.77
+0.01
(+0.06%)
After-Hours: 20:00
Harrow Cash from Financing (TTM): 63.56M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 63.56M |
December 31, 2023 | 126.53M |
September 30, 2023 | 181.57M |
June 30, 2023 | 117.38M |
March 31, 2023 | 117.08M |
December 31, 2022 | 54.14M |
September 30, 2022 | -0.889M |
June 30, 2022 | -0.874M |
March 31, 2022 | 51.48M |
December 31, 2021 | 51.47M |
September 30, 2021 | 50.70M |
June 30, 2021 | 49.93M |
March 31, 2021 | 0.654M |
December 31, 2020 | 1.433M |
September 30, 2020 | 2.838M |
June 30, 2020 | 3.186M |
March 31, 2020 | -0.235M |
December 31, 2019 | -1.006M |
September 30, 2019 | -0.23M |
June 30, 2019 | 2.652M |
March 31, 2019 | 3.456M |
December 31, 2018 | 4.131M |
September 30, 2018 | 3.415M |
June 30, 2018 | 3.069M |
March 31, 2018 | 2.093M |
Date | Value |
---|---|
December 31, 2017 | 4.93M |
September 30, 2017 | 13.13M |
June 30, 2017 | 12.98M |
March 31, 2017 | 13.55M |
December 31, 2016 | 24.67M |
September 30, 2016 | 16.08M |
June 30, 2016 | 14.05M |
March 31, 2016 | 24.61M |
December 31, 2015 | 10.75M |
September 30, 2015 | 10.43M |
June 30, 2015 | 10.62M |
March 31, 2015 | 0.245M |
December 31, 2014 | 0.599M |
September 30, 2014 | 0.617M |
June 30, 2014 | 0.483M |
March 31, 2014 | 0.349M |
December 31, 2013 | 10.05M |
September 30, 2013 | 9.711M |
June 30, 2013 | 13.65M |
March 31, 2013 | 21.51M |
December 31, 2012 | 11.81M |
September 30, 2012 | 12.27M |
June 30, 2012 | 8.350M |
March 31, 2012 | 0.4959M |
December 31, 2011 | 0.1459M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-1.006M
Minimum
Dec 2019
181.57M
Maximum
Sep 2023
43.57M
Average
26.56M
Median
Cash from Financing (TTM) Benchmarks
Durect Corp | 9.002M |
Aquestive Therapeutics Inc | 94.92M |
Cyclacel Pharmaceuticals Inc | 0.848M |
Stereotaxis Inc | 0.055M |
Cara Therapeutics Inc | 36.91M |